Search results for " Pall"
Article
Improving Upstream Predictability
Similarly, Pall Life Sciences has invested in bench-top automation that allows users more control over processes, says Odette Becheau, senior bioprocess application specialist. Pall’s mPath platform f…
Article
Scaling Up Novel Therapies
… and eventually cell therapies,” says Rick Morris, senior vice-president of product development at Pall Corp. In addition, he says, it will speed up and allow for screening of a much larger number of…
Article
Taking a “Development-by-Design” Approach to Cell Therapies
As a growing number of Big Pharma companies explore the potential for immune, regenerative, and other cell therapies, equipment manufacturers including Pall Corp., EMD Millipore, and Cytiva, have set …
Article
Biomanufacturing Outsourcing Globalization Continues
May 02, 2015
By Eric S. Langer
BioPharm International
Volume 28, Issue 5
Biopharmaceutical manufacturing clusters continue to emerge outside of the traditional hubs of North America …
Article
Evolution of the Monoclonal Antibody Purification Platform
The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.
Monoclonal antibodies (mAb) increasingly form the majority share of the product pipeline…
Article
Tools for Continuous Bioprocessing Development
…rging oxygen and carbon dioxide through a permeable membrane at the bottom of the well, as seen with Pall Corporation’s Micro-24 (M24) reactor. The reactor has been demonstrated in microbial cultivat…
Article
Advanced Technologies Facilitate Scale-up and Technology Transfer
…with single-use technologies, according to Helene Pora, vice-president of single-use technologies at Pall Life Sciences. “Single-use systems have proven to not only reduce capital investment, but als…
Article
Securing the Single-Use Supply Chain
As a result, adds Mario Philips, vice-president of single-use technologies at Pall Life Sciences, there is a greater dependence on the single-use supplier, which increases the risk for the manufacture…
Article
Weighing the Benefits of Single-Use Consumables
…e of interview); and Helene Pora, vice-president, Technical Communication & Regulatory Strategy, Pall, to get their perspective on the current benefits of single-use systems.
LEARN MORE HERE!
Article
Gene Therapies Push Viral Vector Production
Gene Therapies Push Viral Vector Production
Viral vectors show promise as a delivery mechanism for gene therapy, but which virus types are commercially viable?
By Feliza Miraso…